Immunocore
IMCR
125 hedge funds and large institutions have $1.92B invested in Immunocore in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 8 closing their positions.
8,356% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $151K
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
38% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 37
4% more funds holding
Funds holding: 120 → 125 (+5)
3.38% more ownership
Funds ownership: 73.44% → 76.82% (+3.4%)
9% less capital invested
Capital invested by funds: $2.12B → $1.92B (-$198M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$30.1M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$26M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.9M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$12.3M |
| 5 |
Millennium Management
New York
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$31.3M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$13.4M |
| 3 |
Barclays
London,
United Kingdom
|
-$7.82M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.01M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.83M |
IMCR Hedge Fund Activity: Q3 2023 in Review
125 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q3 2023, worth a combined $1.92B — down 9.4% from $2.12B a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IMCR positions and 8 closed out — a net gain of 6 holders — while 51 added to existing stakes and 37 trimmed.
The largest buyer was Nicholas Investment Partners, adding an estimated $30.1M. The largest seller was Holocene Advisors, cutting an estimated $31.3M.
- 125 institutional investors held Immunocore (IMCR) as of Q3 2023, up from 120 in Q2 2023.
- Funds reported $1.92B of Immunocore stock for Q3 2023, down 9.4% quarter-over-quarter.
- 14 funds opened new Immunocore positions in Q3 2023 and 8 closed out, a net change of +6 holders.
- The largest Immunocore buyer in Q3 2023 was Nicholas Investment Partners, an estimated $30.1M added.
- The largest Immunocore seller in Q3 2023 was Holocene Advisors, an estimated $31.3M sold.
Based on aggregated 13F filings for Q3 2023.